-
Intercept Pharma Investors Cheering FDA Briefing Doc Release
Tuesday, April 5, 2016 - 10:03am | 337Shares of Intercept Pharmaceuticals Inc (NASDAQ: ICPT) were trading higher by more than 6 percent ahead of Tuesday's market open as investors found the U.S. Food and Drug Administration's latest briefing documents to be encouraging. The FDA has a scheduled advisory committee meeting on Thursday and...